Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
Effective July 25, 2022, and in accordance with the terms of the Acutus Medical,
Inc. 2011 Equity Incentive Plan and the Acutus Medical, Inc. 2020 Equity
Incentive Plan (the "Incentive Plans"), the Board of Directors (the "Board") of
Acutus Medical, Inc. (the "Company") reduced the exercise price of outstanding
options to purchase the Company's common stock held by employees of the Company
who were employed on July 25, 2022 (and who had not provided a notice of
resignation prior to such date) (the "Designated Options") to $1.34 per share,
which was the closing price for the Company's common stock on July 25, 2022. The
exercise price reduction includes options held by, among others, the Company's
Chief Executive Officer, David Roman, with respect to 127,335 shares (with
original exercise prices ranging from $2.41 to $13.66).
Except for the reduction in the exercise price of the Designated Options, all
outstanding stock options continue to remain outstanding in accordance with
their current terms and conditions as set forth in the Incentive Plans and award
agreements thereunder.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
Number Description
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
2
© Edgar Online, source Glimpses